Introduction
============

White matter hyperintensities (WMHs), also known as leukoaraiosis, are commonly seen as confluent or patchy hyperintense areas on T2 weighted or fluid attenuated inversion recovery (FLAIR) scans in the elderly ([@B20]). The presence of WMHs is associated with cognitive impairment and mood disorders, increases the risk of stroke, dementia and mortality ([@B12]; [@B6]). However, the underlying pathogenic mechanisms of WMHs is so far unclear.

Although previous studies have demonstrated that the development of WMHs was related to the damaged blood-brain barrier, disruption of capillary permeability and diminished regional cerebral blood flow ([@B16]; [@B3]; [@B18]). It was also shown that cerebral venous collagenosis may cause venous ischemia and lead to non-necrotic hyperintensities on MRI by increasing vascular resistance and compromising interstitial fluid circulation, with consequent vessel leakage ([@B15]; [@B2]). Recently, [@B22] demonstrated increased number of voxels of deep medullary veins (DMVs) on susceptibility-weighted imaging (SWI) was independently associated with WMHs volume. However, conversely, Guio et al. ([@B5]) observed a significant reduction in the number of visible veins within WMHs in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Actually, pathological changes of veins from intramural stenosis to luminal occlusion is a dynamic process ([@B2]), which may result in different voxel and visibility of veins on images during different stage. The discrepant conclusions may be contributed to the difficulty in repeatability of voxel analysis. Moreover, the venous compartment is responsible for 70 to 80% of the circulatory volume inside the cranial cavity and the classification of superficial and deep cerebral venous system depends on the anatomy of drainage regions across the brain ([@B13]). Thus, it is necessary to investigate the regional association of DMVs and WMHs when considering their possible relationships. Taken them together, we deem it worthy to create a DMVs visual score on SWI and explore the exact relationship of DMVs and WMHs based on venous drainage regions.

Materials and Methods {#s1}
=====================

Study Subjects
--------------

This was an investigator-initiated prospective single-center study. We reviewed the demographic, clinical, laboratory and radiological data of all patients who received brain MRI scan but had no diagnostic intracerebral lesions such as trauma, infection, acute stroke, and space-occupying lesions in our department from January 2010 to April 2016.

Inclusion criteria were: (1) WMHs visible on FLAIR images; (2) age above 30; (3) had written informed consent. Exclusion criteria were: (1) patients with secondary causes of white matter lesions, such as demyelinating, metabolic, immunological, toxic, infectious, and other causes; (2) patients with abnormal brain MRI findings such as head trauma, hemorrhage, infarction (except lacunes) and other space-occupying lesions; (3) patients with definitive peripheral neuropathy, spinal cord disease; (4) evidence of calcification on CT scans or encephalomalacia in the deep gray matter structures since it may influence the observation of DMVs.

Twenty normal control subjects with matched age and gender were recruited from elderly volunteers for the visibility of DMVs after giving written informed consent, who were volunteers of our ongoing functional MRI projects. Their clinical data (for common vascular risk factors such as hypertension, diabetes mellitus and hyperlipidemia), laboratory examinations, and radiological examinations (both MRI and CT) were normal.

Ethics Statement
----------------

All subjects had given written informed consent prior to the study, and the protocols had been approved by the local ethics committee. All clinical investigation has been conducted according to the principles expressed in the Declaration of Helsinki.

MRI Protocol
------------

All subjects underwent multi-model MRI by a 3.0 T MR (MR750, GE Healthcare, United States) scanner using an 8-channel brain phased array coil, including T1, T2, T2 FLAIR, and SWI sequence. In order to minimize head motion, foam pads were inserted into the space between the subject's head and the MRI head coil. Axial T2 FLAIR sequence was used to measure the WMHs volume with the following parameters: repetition time = 8400 ms, echo time = 150 ms, FOV = 24 cm × 24 cm, matrix size = 256 × 256, inversion time = 2100 ms, slice thickness = 4.0 mm with no gap (continuous) between slices, and in-plane spatial resolution of 0.4688 mm/pixel × 0.4688 mm/pixel. The whole brain was imaged. The SWI sequence was in an axial orientation parallel to the anterior commissure to posterior commissure line and covered the whole lateral ventricles, using a three-dimension multi-echo gradient-echo sequence with 11 equally spaced echoes: echo time = 4.5 ms \[first echo\], inter-echo spacing = 4.5 ms, repetition time = 34 ms, FOV = 24 cm × 24 cm, matrix size = 416 × 384, flip angle = 20°, slice thickness = 2.0 mm with no gap between slices, and in-plane spatial resolution of 0.4688 mm/pixel × 0.4688 mm/pixel. Flow compensation was applied. Magnitude and phase images were acquired.

Measurement of DMVs
-------------------

The raw data were transferred to a separate workstation (ADW4.4, GE), and a custom built programwas used to reconstuct the magnitude and phase images.

We assessed DMVs on five consecutive periventricular slices (10 mm thick) of SWI phase images from the level of the ventricles immediately above the basal ganglia to the level of the ventricles immediately disappeared for each patient, considering that these slices cover most of the DMVs. According to medullary venous anatomy ([@B13]), six regions including frontal region, parietal region and occipital region (bilateral, respectively) were separated on the above five slices and the characteristics of the DMVs were then evaluated in each region, respectively (**Figure [1](#F1){ref-type="fig"}**).

![Brain regional division. Three regions were segmented including frontal region, parietal region and occipital region according to medullary venous anatomy. The colored area were PVHs of the different brain regions.](fnagi-09-00269-g001){#F1}

The following four-point score was used for the evaluation of DMVs: Grade 0 - each vein was continuous and had homogeneous signal; Grade 1 -- each vein was continuous, but one or more than one vein had inhomogeneous signal; Grade 2 -- one or more than one vein were not continuous, presented with spot-like hypointensity; Grade 3 -- No observed vein was found continuous (**Figure [2](#F2){ref-type="fig"}**). Two neurologists (RZ and YZ, both with 3 years of neuroimaging review experience), who were completely blinded to the subjects' clinical data and disease state, visually assessed the vascular changes.

![Deep medullary veins (DMVs) visual scores. An example of four-point DMVs score in parietal region: Grade 0 -- each vein was continuous and had homogeneous signal; Grade 1 -- each vein was continuous, but one or more than one vein had inhomogeneous signal; Grade 2 -- one or more than one vein were not continuous, presented with spot-like hypointensity; Grade 3 -- No observed vein was found continuous.](fnagi-09-00269-g002){#F2}

Volumetric Assessments of WMHs
------------------------------

The axial T2 FLAIR images were processed for the quantification of WMHs volume after it was coregistered to the phase images, according to the published methods ([@B7], [@B8]). The segmentation threshold for WMHs was determined a priori as three standard deviations in pixel intensity above the mean of the fitted distribution of brain parenchyma as described previously ([@B8]; [@B21]). Then the automatically segmented lesions were manually checked and corrected by two experienced neuro-radiologists (XY and MZ) who were blinded to all other imaging and clinical data. The manual correction process included: (1) Correction of non-white matter area being labeled as WMH; (2) WMH area not properly labeled as WMH or normal appearing white matter falsely labeled as WMH. Since the intracranial volume (ICV) of each individual was different, we measured the corrected WMHs (cWMHs) volume for further analysis with the following equation: cWMHs volume = (WMHs volume × mean ICV)/ICV. The mean ICV is the mean value of ICV of all patients. The volume of periventricular hyperintensities (PVHs) and deep white matter hyperintensities (DWMHs) were measured, respectively ([@B9]; [@B16]), corrected by the ICV, too. PVHs volume was calculated 10 mm away from everywhere around the lateral ventricles for confluent type ([@B23]). Additionally, the same six regions used for the above measurement of DMVs were used for the volumetric assessment of regional PVHs, which were defined as the sum of PVHs in each region, corrected by the ICV, too (**Figure [1](#F1){ref-type="fig"}**).

Evaluation of Microbleeds and Lacunes
-------------------------------------

Microbleeds were identified according to a field guide of microbleeds detection and interpretation. SWI magnitude images were used to identify microbleeds. Briefly, microbleeds should be small, rounded or circular, well-defined hypointense lesions within brain parenchyma with clear margins ranging from 2 to 10 mm in size ([@B11]). Signal voids caused by sulcal vessels, calcifications, choroid plexus, and low-signal averaging from adjacent bone were excluded ([@B19]).

T2 FLAIR images were used to identify lacunes. Lacunes were defined as cavities with signal intensities similar to cerebrospinal fluid on MRI and with a diameter of 3 to 10 mm which was different from the enlarged Virchow--Robin spaces by the size, shape, and rim ([@B10]).

Reliability and Validity of the Radiological Measurements
---------------------------------------------------------

All the raters were blinded to all other clinical and imaging data of the patients. A single-trained observer (RZ) performed the quantitative assessments of 50 patients twice, at an interval of 3 months apart. Another observer (YZ) independently made the measurements on the same patients. The interobserver intraclass correlation coefficients (ICCs) was 0.94 for grading of DMVs (including each region). The intraobserver ICCs was 0.91 for grading of DMVs (including each region). ICCs were described in detail elsewhere ([@B14]).

Statistical Analysis
--------------------

Patients were dichotomized according to WMHs volume or DMVs scores at the median. Comparison between groups were assessed by using Student's *t*-test for data that followed normal distribution, Mann--Whitney *U* test for data that did not follow normal distribution, and Fisher's Exact test for categorical data. We performed partial Pearson's correlation analysis to determine the correlation between log-transformed corrected cWMHs volume, PVHs volume, DWMHs volume, and DMVs scores, by adjusting for age, and number of lacunes. We also conducted logistic regression analysis to provide an odds ratio statistic in order to facilitate comparison with other known risk factors. Backward stepwise conditional method was used to avoid the unstability resulted from collinearity of the included variables. The log-transformed cWMHs volume and DMVs scores appeared to be acceptably normative. All analyses were performed blinded to participant identifying information. A *p* value of \<0.05 was considered to be statistically significant. All statistical analysis was performed with SPSS package (14.0 for Windows).

Results
=======

Subject Characteristics
-----------------------

Totally, 268 consecutive WMHs patients were enrolled in this study. The main reasons for admission of those patients were transient ischemic attack (TIA) or lacunar ischemic stroke (*n* = 140, 52.2%), dizziness (*n* = 43, 16%), cognitive impairment (*n* = 18, 6.7%), gait disturbance (*n* = 9, 3.4%), anxiety or depression (*n* = 5, 1.9%), incidental finding of WMHs on MRI without symptoms (*n* = 53, 19.8%). Their age were 66.6 ± 11.5 years and cWMHs volume were 14.1 ± 16.3 mL. Among them, 160 (59.7%) subjects presented with microbleeds, and 110 (41.0%) subjects presented with lacunes.

Comparison of the DMVs between WMHs and Controls
------------------------------------------------

There were no significant differences in age and gender between WMHs patients and controls. The DMVs score in WMHs patients was significantly higher than controls \[8 (6--11) vs. 0 (0--2), *p* \< 0.001\].

Univariate and Multivariate Regression Analysis of the WMHs Volume
------------------------------------------------------------------

**Table [1](#T1){ref-type="table"}** showed the baseline characteristics of patients for comparison. We classified the patients into mild cWMHs group (*n* = 134) and severe cWMHs group (*n* = 134) according to the cWMHs volume dichotomized at the median (8.36 mL).

###### 

Basic data in different corrected WMHs (cWMHs) volume groups.

                            cWMHs ≤ 8.36 mL (*n* = 134)   cWMHs \> 8.36 mL (*n* = 134)   *p*-value
  ------------------------- ----------------------------- ------------------------------ -----------
  Age (Y)                   66.26 ± 11.30                 66.89 ± 11.76                  0.657
  Female (Y)                52 (38.8)                     58 (43.2)                      0.456
  Years of education (Y)    6.04 ± 5.52                   6.47 ± 5.29                    0.690
  MMSE                      24.51 ± 6.21                  23.81 ± 5.46                   0.630
  MoCA                      21.42 ± 5.27                  20.16 ± 6.88                   0.406
  Past medical history                                                                   
       Hypertension         90 (67.2)                     97 (72.4)                      0.425
       Diabetes mellitus    28 (20.9)                     32 (23.9)                      0.660
       Hyperlipidemia       38 (28.4)                     33 (24.6)                      0.580
  Clinical variables                                                                     
       SBP (mmHg)           150.91 ± 23.01                148.53 ± 24.55                 0.426
       DBP (mmHg)           84.15 ± 13.52                 83.75 ± 12.30                  0.821
       Glucose (mmol/L)     6.66 ± 2.84                   5.72 ± 2.00                    0.003
       TC (mmol/L)          4.68 ± 0.99                   4.12 ± 1.16                    \<0.001
       THcy (μmol/L)        13.68 ± 8.30                  15.08 ± 7.26                   0.202
       Hs-CRP (mg/L)        4.95 ± 8.33                   7.64 ± 11.50                   0.066
  Radiology data                                                                         
       No. of microbleeds   0 (0--1)                      1 (0--5)                       \<0.001
       No. of lacunes       0 (0--0.25)                   1 (0--4)                       \<0.001
       DMVs score           6 (6--8)                      10 (8--14)                     \<0.001

MMSE, mini-mental state examination; MoCA, Montreal cognitive scores; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; THcy, total homocysteine; Hs-CRP, high-sensitive C-reactive protein; WMHs, white matter hyperintensities; cWMHs, Corrected WMHs; DMVs, deep medullary veins.

Patients with severe cWMHs had higher DMVs scores (*p* \< 0.001), more numbers of CMBs (*p* \< 0.001) and more number of lacunes (*p* \< 0.001), compared with those with mild cWMHs. Glucose and total cholesterol level were lower in patients with severe cWMHs.

Age, glucose level, total cholesterol level, DMVs score and number of lacunes were included in the primary logistic-regression model, and age, glucose level were then removed from the backward stepwise conditional model. The DMVs score was an independent factor for severe cWMHs (*OR* = 1.359; 95% CI: 1.224 to 1.508; *p* \< 0.001), after adjusting for total cholesterol level and number of lacunes.

Univariate and Multivariate Regression Analysis of the DMVs Score
-----------------------------------------------------------------

We classified the patients into high DMVs scores group (*n* = 165) and low DMVs scores group (*n* = 103), according to the DMVs scores dichotomized at the median (8) (**Table [2](#T2){ref-type="table"}**).

###### 

Basic data in different DMVs score groups.

                            DMVs score ≤ 8 (*n* = 165)   DMVs score \> 8 (*n* = 103)   *p*-value
  ------------------------- ---------------------------- ----------------------------- -----------
  Age (Y)                   65.95 ± 11.62                67.57 ± 11.34                 0.269
  Female (Y)                65 (39.4)                    45 (43.7)                     0.444
  Years of education (Y)    6.50 ± 5.39                  6.07 ± 5.39                   0.685
  MMSE                      24.81 ± 5.75                 23.34 ± 5.91                  0.327
  MoCA                      22.23 ± 5.71                 19.13 ± 6.21                  0.040
  Past medical history                                                                 
       Hypertension         115 (69.7)                   72 (69.9)                     1.000
       Diabetes mellitus    33 (20.0)                    27 (26.2)                     0.292
       hyperlipidemia       47 (28.5)                    24 (23.3)                     0.395
  Clinical variables                                                                   
       SBP (mmHg)           149.40 ± 24.71               150.31 ± 22.22                0.769
       DBP (mmHg)           83.94 ± 14.75                83.97 ± 12.36                 0.989
       Glucose (mmol/L)     6.64 ± 2.87                  5.45 ± 1.45                   \<0.001
       TC (mmol/L)          4.38 ± 1.13                  4.37 ± 1.12                   0.962
       THcy (μmol/L)        14.55 ± 9.12                 14.34 ± 5.74                  0.846
       Hs-CRP (mg/L)        4.68 ± 7.38                  8.51 ± 12.59                  0.008
  Radiology data                                                                       
       No. of microbleeds   0 (0--1)                     1 (0--5)                      0.001
       No. of lacunes       0 (0--1)                     1 (0--4)                      \<0.001
       cWMHs volume (mL)    8.59 ± 10.80                 23.04 ± 19.41                 \<0.001
       PVHs volume (mL)     4.75 ± 4.90                  11.63 ± 7.51                  \<0.001
       DWMHs volume (mL)    3.83 ± 7.46                  11.41 ± 13.94                 \<0.001

PVHs, periventricular hyperintensities; DWMHs, deep white matter hyperintensities; other abbreviations same as

Table

2

.

Patients with high DMVs scores had higher cWMHs volume, higher PVHs volume, and higher DWMHs volume, compared with those with low DMVs scores (all *p* \< 0.001). Patients with high DMVs scores had more numbers of microbleeds (*p* = 0.018) and lacunes (*p* \< 0.001). Glucose level were lower in patients with high DMVs scores (*p* \< 0.001), and high-sensitivity C-reactive protein (hs-CRP) level were higher in patients with high DMVs scores (*p* = 0.008).

Since cWMHs volume, PVHs volume, and DWMHs volume were highly correlated with each other, they were included in the logistic-regression model separately. Finally, we found cWMHs volume (OR = 1.048, *p* = 0.001), PVHs volume (OR = 1.166, *p* \< 0.001) and DWMHs volume (OR = 1.051, *p* = 0.007) were all independent factors for high DMVs scores, after adjusting for age, glucose level, Hs-CRP level and number of lacunes.

Relationship between the DMVs and WMHs in Different Regions
-----------------------------------------------------------

Significant correlations were found between DMVs scores and cWMHs volume (Pearson *r* = 0.463, *p* \< 0.001), PVHs volume (Pearson *r* = 0.539, *p* \< 0.001) and DWMHs volume (Pearson *r* = 0.366, *p* \< 0.001), respectively, after adjusting for age, glucose level, Hs-CRP level and number of lacunes.

Additionally, as **Table [3](#T3){ref-type="table"}** shows, the correlation coefficient between DMVs scores and regional PVHs volumes in the same brain region was highest, except left frontal and right occipital region. **Figure [3](#F3){ref-type="fig"}** was an example figure illustrating the regional correlation between DMVs and PVHs.

###### 

The correlation of DMVs and PVHs in different brain regions.

                         Left frontal PVHs   Left parietal PVHs   Left occipital PVHs   Right frontal PVHs   Right parietal PVHs   Right occipital PVHs
  ---------------------- ------------------- -------------------- --------------------- -------------------- --------------------- ----------------------
  Left frontal DMVs      **0.623**           0.545                0.450                 0.631                0.554                 0.302
  Left parietal DMVs     0.359               **0.550**            0.314                 0.379                0.543                 0.349
  Left occipital DMVs    0.438               0.475                **0.556**             0.454                0.480                 0.414
  Right frontal DMVs     0.601               0.516                0.448                 **0.637**            0.527                 0.329
  Right parietal DMVs    0.366               0.542                0.304                 0.378                **0.589**             0.375
  Right occipital DMVs   0.402               0.447                0.547                 0.420                0.440                 **0.422**

p-value \< 0.05. PVHs, periventricular hyperintensities; DMVs, deep medullary veins. Bolded values are the Pearson r values between DMVs scores and PVHs volumes of the same brain regions.

![An example of correlation between deep medullary veins (DMVs) and periventricular hyperintensities (PVHs) in different brain regions. The PVHs in the subject in frontal regions and occipital regions were relatively severe than that of parietal regions, and the DMVs scores in frontal regions and occipital regions (both grade 3) were higher than that of parietal regions (grade 2).](fnagi-09-00269-g003){#F3}

Discussion
==========

In the current study, we proposed a novel visual DMVs score based on brain lobes. We found an independent association between DMVs score and cWMHs volume, especially PVHs volume. Importantly, provided that DMVs mainly participate in the drainage of surrounding white matter, our finding that DMVs scores were correlated with regional PVHs volumes in the same brain region most may indicate that DMVs are involved in the pathogenesis of WMHs.

Postmortem MRI and histopathologic findings have revealed a noninflammatory, periventricular venulopathy with concentric collagen deposition in WMHs, which causes intramural thickening, stenosis and ultimately venous luminal occlusion ([@B15]; [@B2]). Periventricular venous collagenosis was strongly associated with WMHs ([@B4]; [@B2]). The visibility of the venous vessels on SWI depends on the de-oxygenation of the vessel ([@B17]), so the venous heterogeneous signal could be a result of altered venous hemodynamics or venous occlusion ([@B25]). The venous outflow obstruction may contribute to the enlargement of WMHs due to ischemia. Furthermore, from the point of pathologic view, with the progress of intramural thickening and stenosis, luminal occlusion may become the end stage of DMVs disruption, contributing to the uncontinuous, spot-like hypointensity and decreased DMVs, and even no vein identified on SWI ([@B15]). It is thus rational to grade the DMVs based on both heterogeneous signal and the morphology of veins, but not purely on voxel analysis.

Our result supports the possible impact of DMVs drainage pattern on the surrounding white matter, which is consistent with a previous finding that there was relationship between the lesion location and the dilated veins in intracranial venous dysplasia patients, based on the anatomic analysis of the drainage of the medullary vein ([@B13]). In this study, we found that the correlation coefficient between DWMHs and DMVs scores was lower than that between PVHs and DMVs scores. This may be explained that part of DWMHs is drained by the superficial medullary veins. Moreover, the correlation coefficient of the same regional PVHs was higher than other regional PHVs, indicating that DMVs might have a direct influence on the surrounding white matter. Our brain region-based DMVs score may provide a tool for the future study to investigate the venous mechanism of WMHs.

We also found that patients with high DMVs scores had more lacunes. Lacunes most often result from arterial ischemia ([@B1]; [@B10]), which may lead to high de-oxygenation of the vessel, to some extent. Previous studies demonstrated that WMHs are correlated with reduced cerebral metabolism ([@B8]) as well as reduced cerebral blood flow (CBF) on quantitative perfusion MRI ([@B16]). The reduced CBF would lead to the increased oxygen extraction from vessels and cause the subsequent venous heterogeneous signal on SWI, too ([@B24]). Moreover, venous outflow is influenced by the severity of reduction in arterial flow. It is thus reasonable to infer that the extent of upstream arterial ischemia also influences the change of DMVs. Further study to investigate the interaction between cerebral venous disruption and arterial perfusion may help to clarify it.

Our study had limitations. First, the signal to noise ratio (SNR) in SWI phase images is relatively lower than the SNR in minimum intensity projection (mIP) venograms. However, mIP images are lack of three-dimensional information of blood vessels. Besides, our assessment of DMVs was on a 3T brain MRI and the comparatively lower field strength may also reduce the quality of DMVs detection. Second, follow-up data was not available for most patients. Therefore, we cannot assess the natural progression of WMHs and the DMVs and not able to provide the causal relationship of DMVs and WMHs. Longitudinal and prospective studies are needed to clarify if the venous insufficiency contributes to the progression of white matter damage and whether DMVs disruption increases risks of stroke and cognitive decline. Third, although we used continuous thin-slice 3-T MRI scans and set the phase images as reference to minimize the effects of artifact, the step of coregistration may still bring artifact, especially for small structures like DMVs. Fourth, our cohort only included Chinese patients at a single institution who had distinct imaging changes or symptoms, and the exclusion criteria was strict. Therefore, it may not represent the full spectrum of WMHs, and the generalizability of our results need confirmation and extension in larger and multicenter cohorts.

In summary, our findings of cerebral venous insufficiency in WMHs patients could help to elucidate the pathogenic mechanisms and progression of WMHs. The newly proposed DMVs grading method may allow the clinician to monitor the course of DMVs disruption. Moreover, our results may provide insights in new therapies for WMHs targeting cerebral vein, such as to improve venous hemodynamics or increase the venous tone.
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